Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 620,649 |
|
|||||
| News | - | ||||||
| Day High | 67.08 | Low High |
|||||
| Day Low | 65.46 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxcyte Inc | PCVX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.41 | 2.18% | 65.96 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 66.48 | 65.46 | 67.08 | 65.96 | 64.55 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,347 | 620,649 | $ 66.18 | $ 41,076,785 | - | 44.20 - 82.04 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:30:08 | 1 | $ 66.46 | USD |
Vaxcyte Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.15B | 108.41M | - | 0 | -402.27M | -3.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vaxcyte News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PCVX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 60.32 | 67.08 | 58.84 | 62.25 | 562,104 | 5.64 | 9.35% |
| 1 Month | 62.74 | 67.08 | 58.10 | 61.91 | 694,927 | 3.22 | 5.13% |
| 3 Months | 74.28 | 82.04 | 58.10 | 68.62 | 727,316 | -8.32 | -11.20% |
| 6 Months | 48.72 | 82.04 | 46.16 | 64.75 | 780,882 | 17.24 | 35.39% |
| 1 Year | 47.80 | 82.04 | 44.20 | 58.20 | 682,403 | 18.16 | 37.99% |
| 3 Years | 19.25 | 82.04 | 15.51 | 43.65 | 567,317 | 46.71 | 242.65% |
| 5 Years | 23.56 | 82.04 | 15.51 | 42.05 | 503,011 | 42.40 | 179.97% |
Vaxcyte Description
| Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. |
